Chronic kidney disease (CKD) is a complex condition that requires interdisciplinary collaboration to improve prevention, diagnosis, and patient care. Progress in the field depends on the combined efforts of researchers, clinicians, patient organisations, regulatory experts, and many other stakeholders.

Over the years, Mosaiques Diagnostics has contributed to this development through its work in clinical proteomics, including biomarker discovery, data analysis, assay standardisation, and the advancement of personalised medicine approaches for kidney disease.

We are pleased to contribute to the newly launched KidneyHealth COST Action (CA25128), a European network that brings together experts from a wide range of disciplines, including basic and clinical research, nephrology, bioinformatics, artificial intelligence, statistics, epidemiology, regulatory science, and patient advocacy.

The initiative aims to strengthen collaboration across Europe and beyond, facilitating the translation of scientific advances into clinical practice and supporting the development of innovative solutions for patients with chronic kidney disease.

Further information about the KidneyHealth COST Action and opportunities to participate are available on the Action's website: LINK